Sign inJoin waitlistJoin the waitlist

David Aggen

Physician · Memorial Sloan Kettering Bergen

Credentials: · · · · · · ·

History

Memorial Sloan Kettering Bergen
2023–Present

Medical Oncology
2016–2018
Internal Medicine
Wayne State University School of Medicine
2013–2016
University of Illinois Urbana-Champaign
University of Illinois College of Medicine
2009–2013

Research

Single-cell protein activity analysis identifies recurrence-associated renal tumor macrophages
Cell · 2021 · 289 citations
Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non-Clear-Cell Renal Cell Carcinoma and Genomic Correlates
Journal of Clinical Oncology · 2022 · 168 citations
Biomarkers for immunotherapy in bladder cancer: a moving target
Review · Journal for ImmunoTherapy of Cancer · 2017 · First of 2 authors · Corresponding · 145 citations

GI
Gopa Iyer
11 papers
JR
Jonathan Rosenberg
11 papers
HA
Hikmat Al-Ahmadie
9 papers
CD
Charles Drake
7 papers
CL
Chung-Han Lee
7 papers
Eugene Pietzak
7 papers · 7 as a resident
MC
Maria Carlo
7 papers
SF
Samuel Funt
7 papers
BB
Bernard Bochner
6 papers
DM
Deaglan McHugh
6 papers
MV
Martin Voss
6 papers
RK
Ritesh Kotecha
6 papers

Clinical trials

Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer
Principal investigator · Recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
2022–2027
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Site PI · Recruiting · Phase 2, Phase 3
National Cancer Institute (NCI)
2024–2030